GCP Analytics Maturity in Pharma Organizations

This white paper explores the evolution of GCP analytics maturity in top pharma companies, highlighting best practices and strategies for enhancing R&D effectiveness. It examines the framework for assessing maturity, frontier practices in high-performing organizations, and actionable steps for companies to advance their GCP quality analytics capabilities. Key insights are drawn from industry interviews and research, providing a roadmap for improving quality risk management in clinical trials.